Case Studies

Connecting Specialty Drug Data

As a greater number of drugs are distributed through specialty channels, it is difficult to gain deep insights into the patient journey. Single data sources provide limited visibility into the complex journeys for patients on specialty therapies.

Case Study

Building External Control Arms with Real-World Data – A Biopharma Case Study

Building External Control Arms through Real-World Data – A Phase II Oncology Case Study

Case Study

How One Pharma Used Connected Specialty Drug Data and RWD to Improve Patient Adherence

Case Study

How One Pharma Connected Specialty Drug Data for Better Physician Targeting

Case Study

Case Study: Linking EHR, Genomic & Claims Data to Find Ultra-Rare Disease Patients

Case Study

Research Using Connected Health Data

Case Study

Case study: Profiling and Diagnosing Rare Disease Patients

Case Study

Case Study: Trial Tokenization and Linking to Real World Data: Extending the effectiveness and safety analysis of a new focal seizure treatment

Case Study

Case study: Using De-identified Linked Real-World Data to Create an External Control Arm in Non-Small Cell Lung Cancer

Filter By

Connecting Specialty Drug Data

Building External Control Arms with Real-World Data – A Biopharma Case Study

How One Pharma Used Connected Specialty Drug Data and RWD to Improve Patient Adherence

How One Pharma Connected Specialty Drug Data for Better Physician Targeting

Case Study: Linking EHR, Genomic & Claims Data to Find Ultra-Rare Disease Patients

Research Using Connected Health Data

Case study: Profiling and Diagnosing Rare Disease Patients

Case Study: Trial Tokenization and Linking to Real World Data: Extending the effectiveness and safety analysis of a new focal seizure treatment

Case study: Using De-identified Linked Real-World Data to Create an External Control Arm in Non-Small Cell Lung Cancer

STAY CURRENT WITH US